Achillion pharmaceuticals inc

Major-Pharmaceuticals

ACHN


300 George Street
New Haven , CT 06511

Executive/
Director

Links

Price

  • Last Close
  • $ 0.21
    $ +0 0 %
    Dec 9, 2022
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 0
  • Market Cap Full
  • $ 6.3M
  • Shares Outstanding
  • 30M
    Nov 9, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 -19.5% -28.5% 1.9% 28.8% 86.2% -5% - -7.9% - -
Q2 -10.1% 1% 9% -18.9% -12% 4% 1225.5% -28.6% - -
Q3 -22% 3.9% -2.2% 27.8% 31.2% 8% 1225.5% -18.4% - -
Q4 56.2% -49% -39% -56.3% 67.1% - -25.5% 1% - -
J F M A M J J A S O N D
2024 - - - - - - - - - - - -
2023 - - - - - - - - - - - -
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    269%-12%-62%-30%-45%280%12%-94%-46%0%0%

Earnings

2015 2016 2017 2018 2019 2020 2021
Q1 - - - -0.15 -0.14 - -
Q2 - - - -0.12 -0.14 - -
Q3 - - - -0.12 -0.14 - -
Q4 - - - -0.12 - - -
A 0 0 0 -0.5 -0.4 0 0

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 10 10 30 30 30
Jun 10 10 - 30 30 -
Sep 10 10 10 30 30 30
Dec 10 10 30 30 30 30

Financial Ratios

20182017201620152014
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - 0.5 34.1 -
Total Asset Turnover - - - 0.1 -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 13.5 20.6 20.5 1.5 166.1
Equity multiplier - 0.1 0.1 - -